Radiofrequency Ablation for the Papillary Thyroid Micro-carcinoma in the High- risk Surgical Patient

Percutaneous ultrasound-guided Radiofrequencyablation (RFA) is a minimally invasive treatment that has been widely used as an alternative to surgery in the care of patients with malignant tumors of the liver, renal cell carcinoma, and other tumors. Recently, RFA is an alternative treatment modality for benign thyroid nodules instead of surgery, mainly for the cosmetic reasons, and limited cases of local recurrences or focal distant metastases of differentiated thyroid cancer in the high-risk reoperative condition or for the palliative purpose. However, RFA for the initial treatment of the DTC is rare. We report a case of RFA for the papillary thyroid microcarcinomain the high-risk surgical patient. A 49-years-old woman with congestive heart failure due to severe mitral valve regurgitation, chronic kidney disease, and type 2 diabetes was incidentally diagnosed with papillary microcarcinoma without metastasis. She underwent RFA. During 5-year follow-up, there is no recurrence of the findings.